Middlesex Hospital Cancer Center
Middletown, Connecticut, United States
Cancer treatment center in Middletown, Connecticut
536 Saybrook Rd, Middletown, CT 06457
About Middlesex Hospital Cancer Center
"At the Middlesex Health Cancer Center, our expert team uses the most advanced technology to provide evidence-based and compassionate care for the whole person - body, mind, and spirit. Our collaboration with the Mayo Clinic brings the best cancer care closer to home and provides our patients with access to some of the top cancer specialists in the world."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Alliance for Clinical Trials in Oncology
6
NSABP Foundation Inc
3
Radiation Therapy Oncology Group
2
SWOG Cancer Research Network
2
ECOG-ACRIN Cancer Research Group
1
Epigenomics, Inc
1
Gilead Sciences
1
Incyte Corporation
1
Clinical Trials at Middlesex Hospital Cancer Center
During the past decade, Middlesex Hospital Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 11 clinical trials were completed, i.e. on
average, 1100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
2003-10-01
2012-11-01
Completed
732
S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
2004-04-01
2018-10-01
Completed
695
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
2006-08-01
2016-02-01
Completed
1,038
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
2005-11-01
2018-01-01
Completed
2,334
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
2006-08-01
2023-12-01
Active, not recruiting
3,966
Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma
2008-03-01
2014-07-01
Completed
60
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Middlesex Hospital Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 6 trials, followed by "NSABP Foundation Inc" with 3 trials
sponsored, "Radiation Therapy Oncology Group" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 2 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Middlesex Hospital Cancer Center"
#1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator and "North Central Cancer Treatment Group" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Middlesex Hospital Cancer Center
According to Clinical.Site data, the most researched conditions in "Middlesex Hospital Cancer Center" are
"Breast Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Prostate Cancer" (3 trials), "Anal Cancer" (1 trials) and "Breast Adenocarcinoma" (1 trials). Many other conditions were trialed in "Middlesex Hospital Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Middlesex Hospital Cancer Center
Most popular intervention types in "Middlesex Hospital Cancer Center" are "Drug" (13 trials), "Other" (5 trials), "Biological" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (4 trials), "Placebo" (2 trials), "anastrozole" (2 trials), "bevacizumab" (2 trials) and "rituximab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Middlesex Hospital Cancer Center
The vast majority of trials in "Middlesex Hospital Cancer Center" are
11 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Middlesex Hospital Cancer Center
Currently, there are NaN active trials in "Middlesex Hospital Cancer Center".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Middlesex Hospital Cancer Center,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Middlesex Hospital Cancer Center, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 14 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".